These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


135 related items for PubMed ID: 26908847

  • 1. Tooth Discoloration in a Patient With Multidrug-Resistant Tuberculosis.
    Clin Infect Dis; 2016 Mar 01; 62(5):617; 664-5. PubMed ID: 26908847
    [No Abstract] [Full Text] [Related]

  • 2. [Severe linezolid-induced toxic optic neuropathy].
    Xerri O, Lemaire B, Nasser G, Rousseau-Huvey B, Labetoulle M, Rousseau A.
    J Fr Ophtalmol; 2015 Mar 01; 38(3):e55-8. PubMed ID: 25637235
    [No Abstract] [Full Text] [Related]

  • 3. Does linezolid have a role in shortening treatment of tuberculosis?
    Yew WW, Chan DP, Chang KC.
    Clin Microbiol Infect; 2019 Sep 01; 25(9):1060-1062. PubMed ID: 31238119
    [No Abstract] [Full Text] [Related]

  • 4. Linezolid Induced Reversible Peripheral Neuropathy.
    Vishnu VY, Modi M, Goyal MK, Lal V.
    Am J Ther; 2016 Sep 01; 23(6):e1839-e1841. PubMed ID: 26741956
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Linezolid in children with drug resistant tuberculosis.
    Shah I, Dey A, Shetty NS.
    Infect Dis (Lond); 2018 Sep 01; 50(11-12):868-870. PubMed ID: 30296864
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Is Severe and Long-lasting Linezolid-induced Optic Neuropathy Reversible?
    Lee S, Kang BH, Ryu WY, Um SJ, Roh MS, Son C.
    Intern Med; 2018 Dec 15; 57(24):3611-3613. PubMed ID: 30101940
    [Abstract] [Full Text] [Related]

  • 9. Linezolid tolerability in multidrug-resistant tuberculosis: a retrospective study.
    Bolhuis MS, Tiberi S, Sotgiu G, De Lorenzo S, Kosterink JG, van der Werf TS, Migliori GB, Alffenaar JW.
    Eur Respir J; 2015 Oct 15; 46(4):1205-7. PubMed ID: 26160870
    [No Abstract] [Full Text] [Related]

  • 10. Pharmacokinetics of moxifloxacin and linezolid during and after pregnancy in a patient with multidrug-resistant tuberculosis.
    Van Kampenhout E, Bolhuis MS, Alffenaar JC, Oswald LM, Kerstjens HA, de Lange WC, van der Werf TS, Akkerman OW.
    Eur Respir J; 2017 Mar 15; 49(3):. PubMed ID: 28331037
    [No Abstract] [Full Text] [Related]

  • 11. Linezolid-Resistant Enterococcus faecalis Infection Following Prolonged Low-Dosage Linezolid Treatment for Multidrug-Resistant Tuberculosis.
    Baccani I, Antonelli A, Galano A, Bartalesi F, Bartoloni A, Rossolini GM.
    Clin Infect Dis; 2017 Nov 29; 65(12):2159-2160. PubMed ID: 29020204
    [No Abstract] [Full Text] [Related]

  • 12. Linezolid induced toxic optic neuropathy in drug resistant tuberculosis-A case series.
    Vallabhaneni S, Mendonca TM, Nayak RR, Kamath G, Kamath A.
    Indian J Tuberc; 2024 Nov 29; 71 Suppl 1():S5-S9. PubMed ID: 39067955
    [Abstract] [Full Text] [Related]

  • 13. Linezolid to treat MDR-/XDR-tuberculosis: available evidence and future scenarios.
    Sotgiu G, Pontali E, Migliori GB.
    Eur Respir J; 2015 Jan 29; 45(1):25-9. PubMed ID: 25552734
    [No Abstract] [Full Text] [Related]

  • 14. Haematological adverse effects associated with linezolid in patients with drug-resistant tuberculosis: an exploratory study.
    Letswee G, Kamau H, Gaida R, Truter I.
    Int J Pharm Pract; 2019 Dec 29; 27(6):575-577. PubMed ID: 31058394
    [Abstract] [Full Text] [Related]

  • 15. Linezolid-Associated Optic Neuropathy in Drug-Resistant Tuberculosis Patients in Mumbai, India.
    Mehta S, Das M, Laxmeshwar C, Jonckheere S, Thi SS, Isaakidis P.
    PLoS One; 2016 Dec 29; 11(9):e0162138. PubMed ID: 27611434
    [Abstract] [Full Text] [Related]

  • 16. Occurrence and predictors of adverse events associated with Linezolid in the treatment of patients with MDR-TB.
    Oehadian A, Bastos ML, Centis R, D'Ambrosio L, Migliori GB, Santoso P, Ruslami R, Menzies D.
    Pulmonology; 2024 Dec 29; 30(2):184-187. PubMed ID: 37783640
    [No Abstract] [Full Text] [Related]

  • 17. Anemia related to linezolid-based combination regimen in drug-resistant tuberculosis.
    Putra ON, Nur Hidayatullah AY.
    Int J Mycobacteriol; 2022 Dec 29; 11(1):130-131. PubMed ID: 35295038
    [No Abstract] [Full Text] [Related]

  • 18. Linezolid-containing Treatment Regimens for Tuberculosis in Children.
    Prieto LM, Santiago B, Del Rosal T, Carazo B, Jiménez AB, Pérez-Gorricho B, Rubio F, Tagarro A, Blázquez-Gamero D, Moreno-Pérez D, Mellado MJ, Baquero-Artigao F, Spanish Paediatric TB Research Network (pTBred).
    Pediatr Infect Dis J; 2019 Mar 29; 38(3):263-267. PubMed ID: 29750764
    [Abstract] [Full Text] [Related]

  • 19. Role for Linezolid in drug sensitive tuberculosis.
    Ramesh Kumar S, Narendran G, Padmapriyadarsini C.
    J Infect Public Health; 2024 Jan 29; 17(1):172-174. PubMed ID: 38039860
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 7.